Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Latest News

First and Only FDA-Approved Trifocal Lens Now at Ophthalmic Consultants of the Capital Region

Albany, New York—September 4, 2019 Always committed to bringing patients the best and latest technology in the field of eye care, Ophthalmic Consultants of the Capital Region is now among the earliest in the country to offer its cataract patients the first and only FDA-approved trifocal lens. Dr. Allen Zieker implanted the AcrySof® IQ PanOptix® Trifocal Intraocular […]Read More >

NY Top Docs Names Dr. David Rabady a 2019 Leading Provider

Dr. David Rabady, M.D., of Ophthalmic Consultants of Capital Region, has recently been reviewed and approved as a 2019 top provider by NY Top Docs. Dr. Rabady is a retina specialist and a partner at Ophthalmic Consultants of the Capital Region. He treats various retinal diseases such as macular degeneration, macular pucker, diabetic retinopathy, flashes […]Read More >

Lyme Disease and the Eyes: Plus New Research for Better Diagnosis

The hiking, boating, and camping season is here! With the Adirondack Mountains to the north, the Catskill Mountains to the south, and the Green Mountain National Forest to the east, the Capital Region is surrounded by fantastic wilderness to explore. But this also means we are, unfortunately, surrounded by ticks and the presence of Lyme […]Read More >

Dr. David Rabady Honored With Vitals 2019 Patients’ Choice Award.

Albany, New York—May 31, 2019 Ophthalmic Consultants of the Capital Region’s own Dr. David Rabady, M.D., has been named a winner of Vitals’ 11th annual Patients’ Choice Award and is recognized as one of New York’s favorite physicians. Vitals, a Lyndhurst, New Jersey-based healthcare database company, selects its award winners based on millions of patient […]Read More >

Dr. Allen W. Zieker among first 10 surgeons in U.S. to implant DEXTENZA® device for pain management following ophthalmic surgery.  

Albany, New York—May, 30 2019 Allen W. Zieker, M.D., President and Director of Cataract Surgery at Ophthalmic Consultants of the Capital Region, is the first surgeon in the entire Northeast, including New York City, to implant the DEXTENZA® device in ophthalmic surgery patients. DEXTENZA, from the biopharmaceutical company Ocular Therapeutix™, Inc., was approved for use […]Read More >

New Technology: NGENUITY

At Ophthalmic Consultants of the Capital Region, our highly-experienced ophthalmologists make it a priority to stay abreast on the newest, most cutting edge technology to provide every patient with the best care possible. It is with this commitment that our ophthalmologists are excited to announce using the NGENUITY 3D Visualization System with DATAFUSION for retina […]Read More >


On February 12, 2019, Allen Zieker, M.D. of Ophthalmic Consultants of the Capital Region, implanted the Hydrus® Microstent in four glaucoma patients during cataract surgery. The Hydrus Microstent was approved by the FDA in August 2018 and is an implantable, flexible, metal tube designed to reduce eye pressure in patients with mild to moderate primary […]Read More >

Quick Guide to Diabetes and Your Eyes

By David Rabady, M.D. The effects of diabetes extend well beyond the inability to properly metabolize food. Too-high levels of blood sugar can negatively affect all areas of the body…including the eyes. People who have diabetes are at an increased risk of developing eye complications, the most common of which is diabetic retinopathy. Diabetic retinopathy […]Read More >

Secondary Cataracts

Q: I’ve heard of something called “secondary cataracts.” Is it true that cataracts can return after cataract surgery? Will I need to have cataract surgery a second time? By: Allen W. Zieker, M.D. Robert B. Feldman, M.D. Cataract Surgeons at Ophthalmic Consultants of the Capital Region A: Cataracts are actually unable to grow back after […]Read More >

Call Now Button